We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
List of all the tools and techniques in the toolkit.
Prevent safeguards people vulnerable to radicalisation. This survey explores knowledge and attitudes towards Prevent, extremism and signs of radicalisation.
Find out what to do if you are spiked, or are with someone who has been, and where to get more information.
Employment Tribunal decision.
Data tables tracking the affordability of communication services among UK adults from October 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
Papers prepared by Centre for the Mathematical Modelling of Infectious Diseases (CMMID) COVID-19 Working Group.
A Foreign Office Research Analyst paper.
This section helps you to understand users and their needs and begin to diagnose the policy problems and challenges that you need to fix.
Chancellor of the Exchequer delivers his first Mansion House speech on the evening of Monday 10 July.
First published during the 2022 to 2024 Sunak Conservative government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).